AURA
Price
$6.56
Change
+$0.10 (+1.55%)
Updated
Jul 3 closing price
Capitalization
406.75M
32 days until earnings call
IDYA
Price
$22.10
Change
+$0.18 (+0.82%)
Updated
Jul 3 closing price
Capitalization
1.94B
37 days until earnings call
Interact to see
Advertisement

AURA vs IDYA

Header iconAURA vs IDYA Comparison
Open Charts AURA vs IDYABanner chart's image
Aura Biosciences
Price$6.56
Change+$0.10 (+1.55%)
Volume$127.52K
Capitalization406.75M
IDEAYA Biosciences
Price$22.10
Change+$0.18 (+0.82%)
Volume$522.89K
Capitalization1.94B
AURA vs IDYA Comparison Chart in %
Loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURA vs. IDYA commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Hold and IDYA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (AURA: $6.56 vs. IDYA: $22.10)
Brand notoriety: AURA and IDYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 55% vs. IDYA: 43%
Market capitalization -- AURA: $406.75M vs. IDYA: $1.94B
AURA [@Biotechnology] is valued at $406.75M. IDYA’s [@Biotechnology] market capitalization is $1.94B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 0 FA rating(s) are green whileIDYA’s FA Score has 0 green FA rating(s).

  • AURA’s FA Score: 0 green, 5 red.
  • IDYA’s FA Score: 0 green, 5 red.
According to our system of comparison, AURA is a better buy in the long-term than IDYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 5 TA indicator(s) are bullish while IDYA’s TA Score has 5 bullish TA indicator(s).

  • AURA’s TA Score: 5 bullish, 3 bearish.
  • IDYA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both AURA and IDYA are a good buy in the short-term.

Price Growth

AURA (@Biotechnology) experienced а +4.29% price change this week, while IDYA (@Biotechnology) price change was -0.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

AURA is expected to report earnings on Aug 07, 2025.

IDYA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($1.94B) has a higher market cap than AURA($407M). IDYA YTD gains are higher at: -14.008 vs. AURA (-20.195). AURA has higher annual earnings (EBITDA): -101.63M vs. IDYA (-356.46M). IDYA has more cash in the bank: 693M vs. AURA (128M). AURA has less debt than IDYA: AURA (18.4M) vs IDYA (26M). IDYA has higher revenues than AURA: IDYA (7M) vs AURA (0).
AURAIDYAAURA / IDYA
Capitalization407M1.94B21%
EBITDA-101.63M-356.46M29%
Gain YTD-20.195-14.008144%
P/E RatioN/AN/A-
Revenue07M-
Total Cash128M693M18%
Total Debt18.4M26M71%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
66
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AURAIDYA
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
63%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
72%
Momentum
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
75%
MACD
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
75%
Bearish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 7 days ago
84%
Bearish Trend 7 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
75%
Aroon
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SCIRX117.961.68
+1.44%
Columbia Seligman Tech & Info R
NLCCX33.850.40
+1.20%
Voya Large-Cap Growth C
FFBFX29.160.28
+0.97%
Emerald Finance & Bking Innovt Fd Inv
JBSOX22.970.18
+0.79%
JHancock New Opportunities C
ABSZX20.690.12
+0.58%
AB Discovery Value Z

AURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AURA has been loosely correlated with MGTX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if AURA jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURA
1D Price
Change %
AURA100%
+1.55%
MGTX - AURA
53%
Loosely correlated
+8.53%
VRDN - AURA
52%
Loosely correlated
+2.89%
IDYA - AURA
51%
Loosely correlated
+0.82%
BEAM - AURA
50%
Loosely correlated
+0.65%
CCCC - AURA
49%
Loosely correlated
-2.63%
More

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with IMNM. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+0.82%
IMNM - IDYA
60%
Loosely correlated
+2.43%
CGON - IDYA
60%
Loosely correlated
+0.82%
NRIX - IDYA
59%
Loosely correlated
+2.33%
DNLI - IDYA
56%
Loosely correlated
-1.41%
XENE - IDYA
56%
Loosely correlated
-0.33%
More